Clinical Trial Update: Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 completed trial comparing NOMAC-E2 combined oral contraceptive to LNG/EE in terms of effects on bone mineral density.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• LNG/EE (levonorgestrel/ethinyl estradiol)
• NOMAC-E2 (nomegestrol acetate / 17β-estradiol)

Snippet

Sponsor: Organon and Co | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2011-08-29